Botulinum toxin type A for genitofemoral neuralgia: A case report.
botulinum toxin type A
genitofemoral nerve
genitofemoral neuralgia
neuralgia
pain
Journal
Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899
Informations de publication
Date de publication:
2023
2023
Historique:
received:
24
05
2023
accepted:
19
06
2023
medline:
19
7
2023
pubmed:
19
7
2023
entrez:
19
7
2023
Statut:
epublish
Résumé
Genitofemoral neuralgia is an uncommon pain disorder that could be resistant to conventional treatment. A 78-year-old woman with refractory right genitofemoral neuralgia was treated with BoNT/A subcutaneous injections; the treatment was performed three times with significant pain improvement, although temporary, and without adverse events. BoNT/A may be a promising alternative intervention in the setting of genitofemoral neuralgia refractory to oral and/or topical treatment.
Identifiants
pubmed: 37465764
doi: 10.3389/fneur.2023.1228098
pmc: PMC10350489
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1228098Informations de copyright
Copyright © 2023 Tereshko, Enrico, Christian, Dal Bello, Merlino, Gigli and Valente.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Br J Pharmacol. 2016 Jan;173(2):279-91
pubmed: 26493010
Neurourol Urodyn. 2011 Jan;30(1):93-6
pubmed: 20589903
Scand J Pain. 2018 Jan 26;18(1):99-107
pubmed: 29794282
Pain Med. 2010 May;11(5):785-9
pubmed: 20546515
Toxins (Basel). 2017 Aug 24;9(9):
pubmed: 28837075
Toxins (Basel). 2023 Apr 06;15(4):
pubmed: 37104212
Front Neurol. 2020 Aug 11;11:716
pubmed: 32849195
J Headache Pain. 2016 Dec;17(1):63
pubmed: 27377706
Lancet Neurol. 2016 May;15(6):555-65
pubmed: 26947719
J Neural Transm (Vienna). 2014 Jun;121(6):665-9
pubmed: 24420081
Neuroscience. 2011 Feb 23;175:358-66
pubmed: 21111791
Turk Neurosurg. 2013;23(6):753-7
pubmed: 24310458
Neurosurgery. 2005 Feb;56(2):298-303; discussion 298-303
pubmed: 15670378
Turk Neurosurg. 2019;29(4):530-237
pubmed: 30829381
Biochem Pharmacol. 2000 Jun 1;59(11):1403-6
pubmed: 10751549
PLoS One. 2012;7(10):e47977
pubmed: 23110146
Toxins (Basel). 2022 Jan 03;14(1):
pubmed: 35051013
J Biol Chem. 1992 Oct 25;267(30):21338-43
pubmed: 1356988
Pain Physician. 2009 Nov-Dec;12(6):997-1000
pubmed: 19935984
Toxins (Basel). 2015 Aug 14;7(8):3127-54
pubmed: 26287242
PLoS One. 2012;7(1):e29803
pubmed: 22238656
Headache. 2008 Nov-Dec;48(10):1476-81
pubmed: 19076646
Front Cell Infect Microbiol. 2017 Apr 26;7:141
pubmed: 28491822
Clin Anat. 2015 Jan;28(1):128-35
pubmed: 25377757
Neuropharmacology. 2013 Jul;70:331-7
pubmed: 23499661
Headache. 2004 Jan;44(1):35-42; discussion 42-3
pubmed: 14979881
Pain Physician. 2022 Mar;25(2):E357-E364
pubmed: 35322991
Arch Surg. 1984 Mar;119(3):339-41
pubmed: 6696629
J Manipulative Physiol Ther. 2004 Jan;27(1):26-35
pubmed: 14739871
Surg Endosc. 2003 Feb;17(2):196-200
pubmed: 12457217
Pain Physician. 2003 Jul;6(3):345-60
pubmed: 16880882
Eur J Pharmacol. 1989 May 2;164(1):45-53
pubmed: 2568939
Ann Ital Chir. 2022;93:377-384
pubmed: 36155937
Indian J Palliat Care. 2011 May;17(2):108-15
pubmed: 21976850
Neurobiol Dis. 2012 Dec;48(3):367-78
pubmed: 22820141
J Pain Res. 2011;4:347-55
pubmed: 22090803
Neurobiol Dis. 2015 Jul;79:111-22
pubmed: 25958249
Pain. 2014 Aug;155(8):1516-1526
pubmed: 24793910
Pain Med. 2020 Dec 25;21(12):3263-3269
pubmed: 32918473
Toxins (Basel). 2022 Jun 16;14(6):
pubmed: 35737072